Machein Marcia, de Miguel Lourdes Sánchez
Department of Neurosurgery, University of Freiburg Medical School, Breisacher Str. 64, Freiburg 79106, Germany.
Recent Results Cancer Res. 2009;171:193-215. doi: 10.1007/978-3-540-31206-2_12.
Angiogenesis, the sprouting of new blood vessels from preexisting blood vessels, is a hallmark of glioma progression. Malignant gliomas are among the most lethal tumors with a very dismal prognosis, despite advances in standard therapy, including surgery, radiation, and chemotherapy. The median survival of patients with malignant gliomas has changed little in the last few years and is still measured in months. In an attempt to develop new therapeutic strategies and identify the molecular mechanism involved in glioma growth and progression, there has been extraordinary scientific interest in the past 2 decades in angiogenic responses associated with gliomas. This chapter focuses on the molecular mechanism of glioma angiogenesis and summarizes some of the therapeutic approaches based on antiangiogenesis.
血管生成,即从已有的血管中长出新的血管,是胶质瘤进展的一个标志。恶性胶质瘤是最致命的肿瘤之一,尽管包括手术、放疗和化疗在内的标准治疗取得了进展,但其预后仍然很差。恶性胶质瘤患者的中位生存期在过去几年几乎没有变化,仍以月计算。为了开发新的治疗策略并确定胶质瘤生长和进展所涉及的分子机制,在过去20年里,人们对与胶质瘤相关的血管生成反应产生了极大的科学兴趣。本章重点介绍胶质瘤血管生成的分子机制,并总结一些基于抗血管生成的治疗方法。